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Abstract 
 
The role of Fosl1 in transdifferentiation of embryonic stem (ES) cells to 
trophoblast giant-like cells 
 
Nadima Uprety, M.A. 
The University of Texas at Austin, 2016 
 
Supervisor: Jonghwan Kim 
 
During mammalian embryonic development, the first lineage commitment event gives 
rise to two distinct cell populations: the trophectoderm (TE) and the inner cell mass 
(ICM). The TE consists of outer cells of the blastocyst and ultimately forms the placenta 
while the ICM gives rise to all the embryonic tissues. Numerous transcription factors 
(TFs) guiding ICM differentiation into different embryonic tissues have been 
characterized. However, only a few TFs that are required for TE specification and 
differentiation have been identified, and much less is understood as to how these TFs 
interact with other TFs or with their chromosomal targets in order to drive cell fate 
towards TE lineage. Understanding TE development is crucial because cells in this 
lineage are required for proper embryo implantation in the uterus. Defects in TE lineage 
can cause early failure of pregnancy as well as other pregnancy related disorders such as 
preeclampsia and intrauterine growth restriction (IUGR). Here, we characterize the 
function of one of TE-specific TFs, Fosl1, which was previously suggested as having 
 vi 
some roles in placental development. We utilized mouse embryonic stem (ES) cells 
(derived from ICM) and showed that ectopic expression of Fosl1 can transdifferentiate 
ES cells to trophoblast giant-like cells. We show that Fosl1 does so by directly binding 
and activating TE-specific genes and genes associated with epithelial-mesenchymal 
transition (EMT). Using mouse trophoblast stem (TS) cells, we also establish that Fosl1 
is required for specification of TS cells to trophoblast giant cells (TGCs) subtype. 
Therefore, our results suggest that Fosl1 serves as an important mediator of cell fate 
conversion from ES cells to trophoblast giant-like cells and that Fosl1 is a critical 
regulator of TS cell differentiation. 
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Chapter 1: Introduction 
1.1 Early mouse development 
1.1.1 The first cell fate decision: Inner Cell Mass (ICM) versus Trophectoderm (TE) 
During early embryonic development, a totipotent cell undergoes a series of cell 
divisions. In the first stages of division, all of these cells are identical. However, from 8 
cells to 32 cells stage, blastomeres compact and divide either symmetrically or 
asymmetrically to the cleavage plane and produce two distinct cell population for the first 
time during embryogenesis: apolar inner cells and polar outer cells (Senner and 
Hemberger, 2010). Apolar inner cells develop into the inner cell mass (ICM) while polar 
outer cells form the outer trophectoderm (TE) layer. Prior to this, blastomeres are capable 
of adopting either of the two fates. The ICM differentiates into the three germ layers, 
known as the endoderm, mesoderm, and ectoderm, which form all of the tissues of the 
fetus. The TE gives rise to all of the specialized cells of the placenta, a transient yet 
crucial organ that nourishes and protects the developing embryo during pregnancy. The 
lineage determination of these two cell populations is not only determined spatially, but 
also by the interplay of various transcription factors (TFs), which activate or repress cell 
type-specific transcriptional programs. 
The first cell fate decision is controlled by multiple TFs, mainly Oct4 and Cdx2. During 
development, all blastomeres express Oct4 and Cdx2. However, after the first cell fate 
decision, Oct4-expressing cells are restricted to the ICM while Cdx2-expressing cells are 
restricted to TE (Ralston and Rossant, 2008). Studies have shown that Oct4-/- conceptuses 
give rise to blastomere that is committed to trophoblast fate, independent of polarity cues 
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(Nichols et al., 1998). Cdx2-/- embryos fail to maintain epithelial integrity despite 
undergoing lineage commitment, and they do not implant. These Cdx2-/- cells are also 
devoid of potential to differentiate further into trophoblast subtypes (Strumpf et al., 
2005). These data suggest that Oct4 and Cdx2 play critical roles in ICM and TE 
development, respectively. Interestingly, using mouse embryonic stem (ES) cells, it has 
been shown that Oct4 and Cdx2 also negatively regulate each other and that Oct4 
repression or Cdx2 induction can transdifferentiate ES cells to trophoblast stem (TS)-like 
cells (Niwa et al., 2005).  
In addition to Oct4 and Cdx2, the TF Tead4 also plays an important role in establishing 
TE population. The Hippo pathway, which is activated in response to cell-to-cell 
contacts, spatially controls Tead4 expression (Nishioka et al., 2009). Yap1 is a co-factor 
of Tead4 and required for activation of TE-specific genes. In inner cells, where this 
pathway is active, Yap1 (co-factor of Tead4) is phosphorylated by Lats kinase, excluded 
from the nucleus and degraded. Due to absence of Yap1 in the nucleus, Tead4 cannot 
stimulate expression of Cdx2. Thereby, Oct4 becomes dominant and inner cells cannot 
differentiate into TE lineages. In outer cells, where Hippo pathway is inactive, nuclear 
localized Yap1 can form Tead4-Yap1 complex and promote expression of Cdx2 
(Nishioka et al., 2009), which further activates TE marker genes, while repressing Oct4 
activity (Niwa et al., 2005). Mouse studies have shown that Tead4 knockout (KO) 
mutants die due to failure to form blastocoel (fluid filled cavity of blastocyst). 
Interestingly, Tead4 KO cells also lack Cdx2 expression (Nishioka et al., 2008), 
suggesting that Tead4 remains at the top of the transcriptional network hierarchy 
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determining TE segregation from ICM. Gata3, another important TF for TE development, 
has been proposed to work downstream of Tead4 and parallel to Cdx2 to promote TE 
specification by activating genes critical in TE development (Home et al. 2009; Ralston 
et al. 2010). Gata3 was also shown to be able to induce trophoblast fate in ES cells when 
overexpressed and plays important roles in the differentiation of TS cells towards more 
specialized subtypes (discussed below) (Ralston et al. 2010). 
 
1.1.2 The TE lineage and the placenta 
Similar to the ICM which can give rise to cells of various lineages that comprise the fetus 
(ectoderm, mesoderm and endoderm), the TE lineage is capable of giving rise to various 
trophoblast cell subtypes: trophoblast giant cells (TGCs), spongiotrophoblasts, glycogen 
cells, and syncytialtrophoblasts (Ain et al., 2003; Rossant and Cross, 2001; Soares et al., 
1996). TS cells represent the precursors of these differentiated cells of the placenta. Each 
of the subtypes possesses unique functions necessary for development of a healthy 
placenta. However, our understanding of how these different subtypes arise during 
development from a single layered TE is still incomplete.  
TGCs are the first subtype to arise and do so during two phases of development: 1) at the 
blastocyst stage, and 2) after implantation. Primary TGCs arise at the blastocyst stage 
from mural TE, which is TE that is not in contact with ICM due to formation of 
blastocoel (Cross et al., 1994). These cells go through endoreplication, through which 
they enlarge and undergo rounds of DNA replication without entering mitosis (MacAuley 
et al., 1998). Secondary TGCs arise after implantation where cells in the ectoplacental 
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cone, which is the thickened trophoblast of the blastocyst that becomes the fetal portion 
of the placenta, differentiate into TGCs (Cross et al., 1994). These cells have invasive and 
endocrine functions (Riley et al., 1998). They facilitate the process of implantation of the 
embryo into the uterus and also produce several hormones and cytokines that promote 
physiological adaptations in the mother such as regulation of maternal blood flow to the 
implantation site and production of progesterone from the ovary (Cross et al., 2002; 
Linzer and Fisher, 1999).  
Another important subtype of cells making up the placenta are the spongiotrophoblasts, 
which arise from the ectoplacental cone. Even though the function of this cell type is not 
completely known, it is speculated that spongiotrophoblasts perform endocrine functions 
by producing factors such as anti-angiogenic factors that may prevent the growth of 
maternal blood vessels into the fetal placenta (Cross et al., 2002). Spongiotrophoblasts 
also give rise to secondary TGCs. Glycogen cells appear within the spongiotrophoblast 
layer and also give rise to invasive trophoblast cells that penetrate the maternal uterus, 
which increases blood flow to the placenta (Adamson et al., 2002). Syncytialtrophoblasts 
arise from the fusion of multiple trophoblast cells that have left the cell cycle and these 
cells help transport nutrients and waste between maternal and fetal tissues (Cross, 2000). 
Together, all of these differentiated cell subtypes mediate separate yet crucial functions 
of maintaining a healthy placenta.  
The differentiation of cells in TE lineage towards more specialized TGCs is regulated by 
various basic helix-loop- helix (bHLH) TFs like Mash2 and Hand1. Expression of Mash2 
and Hand1 overlaps in the ectoplacental cone and spongiotrophoblasts, which are the 
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precursors of secondary TGCs. However, Mash2 suppresses differentiation to TGCs and 
maintains proliferation of such precursors, i.e. spongiotrophoblast, whereas Hand1 
promotes the formation of TGCs suggesting that these two TFs antagonize one another 
(Scott et al., 2000). TFs like Flt1 and Tpbqa are also expressed within the 
spongiotrophoblasts. Initiation of differentiation towards syncytialtrophoblasts is under 
the control of another TF Gcm1. Ectopic expression of Gcm1 is sufficient to promote 
differentiation of TS cells towards the syncytialtrophoblast fate and block their ability to 
differentiate into TGCs (Hughes et al., 2004). TS cells cultured in vitro (discussed in later 
sections) also readily differentiate into TGCs after withdrawal of Fgf4 and heparin from 
the culture medium (Simmons and Cross, 2005). 
These various cellular subtypes comprise the placenta, the first organ to form during 
mammalian embryogenesis and is vital for the survival of the embryo (Cross et al. 2001). 
Due to these cells, placenta becomes an interface between fetal and maternal environment 
and is responsible for exchange of gases, nutrients and waste products. Placenta is an 
important source of pregnancy-associated hormones and growth factors and therefore, 
any genetic or environmental factor that affects the placenta leads to fetal growth 
retardation and even death (Rossant and Cross, 2001). Therefore, furthering our 
understanding of trophoblast development will provide novel insights into placental 
function. 
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1.1.3 The second cell fate decision: Epiblast (Epi) vs Primitive Endoderm (PrE) 
During the second cell fate decision, the ICM gives rise to the epiblast (Epi) and 
primitive endoderm (PrE). This separation occurs from around embryonic day (E) 3.5 to 
4.5 and is marked by the expression of TFs, Nanog and Gata6 in Epi and PrE, 
respectively (Chambers et al., 2003; Mitsui et al., 2003). Nanog and Gata6 are initially 
co-expressed in ICM and gradually localize in a ‘salt and pepper pattern’ (Rossant et al., 
2003). Nanog expression is followed by expression of Oct4 and Sox2 in Epi (Avilion et 
al., 2003; Rosner et al., 1990; Schöler et al., 1990), while in PrE, the expression of Gata6 
is followed by the expression of Sox17, Gata4, Sox7, and Hnf4 (Arceci et al., 1993; 
Duncan et al., 1994; Masui et al., 2007; Morris et al., 2010; Niakan et al., 2013; Plusa et 
al., 2008). Together, these groups of TFs guide different populations within the ICM 
toward Epi and PrE lineages. Studies have implicated the Fgf signaling pathway in this 
mutually exclusive expression pattern of Nanog and Gata6 and the specification of Epi 
and PrE. While Fgf4 is upregulated in Epi precursor cells, its receptor Fgfr2 is 
downregulated. In PrE precursor cells however, Fgfr2 expression is maintained while 
Fgf4 is downregulated (Guo et al., 2010). This distribution is taken as the first sign of 
lineage commitment within ICM.  
 
1.2  Mouse Stem Cells as Model System 
The use of in vitro model systems represents a valuable tool for understanding cellular 
development. Mouse ES cells, derived from the ICM, and mouse TS cells, derived from 
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the TE, have become invaluable resources for investigating molecular mechanisms and 
pathways underlying early mammalian development of both lineages. 
 
1.2.1 Embryonic Stem (ES) cells 
ES cells were established by isolating the mouse blastocyst and cultivating them on 
feeder cells (mitotically inactive mouse embryonic fibroblasts-MEFs) (Evans and 
Kaufman, 1981). The cells were then expanded and once established, had the potential to 
self-renew and retained the ability to contribute to all embryonic germ lineages. Since ES 
cells required layer of feeder cells to grow, it suggested that these cells provided ES cells 
with some critical factors that allowed them to proliferate or to suppress differentiation. 
Later, two groups independently identified the factor as leukemia inhibitory factor (LIF) 
(Smith et al., 1988; Williams et al., 1988). This discovery allowed for the replacement of 
the feeder layers with cytokine LIF in the media. One of the signaling pathways regulated 
by LIF is the JAK/STAT3 pathway. Inactivation of STAT3 has been shown to promote 
spontaneous differentiation of ES cells in vitro (Boeuf et al., 1997). LIF also activates 
other wide range of downstream effector molecules such as extracellular signal-regulated 
kinases (ERK), mitogen-activated protein kinases (MAPK) and phosphatydilinositol-3 
kinase (PI3K). It was shown that inhibition of ERK pathway favors ES cells self-renewal 
in culture and impairs differentiation (Burdon et al., 1999). PI3K and Wnt pathway both 
inhibit Gsk3, which allows ES cells to promote self-renewal (Reya and Clevers, 2005; 
Watanabe et al., 2006). This suggested that there is a fine balance between positive and 
negative regulator of self-renewal under the control of LIF. Now, combination of 
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inhibitors of Erk and Gsk3 has allowed us to use the 2 inhibitors (2i) condition for 
derivation of ES cells, which is suggested to mimic the environment in mouse ICM and 
allows ES cells to enter naïve ground state where ES cells are more homogeneous and 
“ICM-like” (Guo et al., 2010; Ying et al., 2008). 
Along with the signaling pathways, transcriptional regulators also affect self-renewal and 
differentiation of ES cells. At the top of the hierarchy of the transcriptional network is 
Oct4, one of the master regulators of pluripotency. The precise amount of Oct4 is critical 
for self-renewal of ES cells as upregulation or downregulation of Oct4 causes ES cells to 
transdifferentiate towards PrE and TE lineage, respectively (Niwa et al. 2000). Another 
critical TF involved in maintenance of ES cell self-renewal is Sox2, with which Oct4 
interacts. ES cells deficient in Sox2 also transdifferentiate towards TE lineage (Masui et 
al., 2007). Nanog also plays an important role in maintaining ES cell pluripotency as ES 
cells cannot be derived from Nanog-/- conceptuses (Silva et al., 2009). However, it has 
also been shown that Esrrb can slightly compensate for Nanog deficiency (Festuccia et 
al., 2012). The three core TFs Oct4, Nanog and Sox2 share similar chromosomal targets 
in an interconnected autoregulatory loop (Boyer et al., 2005) and are key in sustaining 
self-renewal in ES cells. 
 
1.2.2 Trophoblast Stem (TS) cells 
 TS cells are derived from either TE of blastocyst or extra-embryonic ectoderm (ExE) and 
are cultured in the presence of MEF cells (Tanaka et al., 1998). However, it was found 
that conditioned medium supplemented with Fgf4 and its co-activator heparin was able to 
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replace the need for feeder cells. Conditioned medium contained factors released by MEF 
cells, which later was found to be TGF-β and activin-A (Erlebacher et al. 2004). In the 
presence of these factors, TS cells maintain self-renewal, i.e. they proliferate without 
undergoing differentiation. However, removal of Fgf4 results in differentiation of TS 
cells. TS cells can differentiate into all trophoblast cell types, in vitro and when injected 
into the blastocyst, they become part of extra-embryonic tissues and placenta (Tanaka et 
al., 1998). Apart from Hippo pathway and Fgf4 mentioned earlier, the Ras-Mapk 
pathway is involved in TE specification as well, where consecutive activation of H-Ras in 
ES cells has been shown to transdifferentiate ES cells into self-renewing TS-like cells 
(Lu et al., 2008).  
The key TFs that promote self-renewal of TS cells comprise of Cdx2, Tead4, Tcfapc2, 
Esrrb, and Eomes. These TFs have the ability to convert ES cells to TS-like cells when 
overexpressed in ES cells (Senner and Hemberger, 2010). Another group of TFs, 
including Gata3, Ets2 and Elf5, not only possess the ability to transdifferentiate ES cells 
but also trigger trophoblast differentiation (Senner and Hemberger, 2010). Therefore, the 
functions of TFs involved in TS cell network are divided into two groups: one that allows 
for self-renewal of TS cells and other that promotes differentiation. Like ES cell core 
factors, these TFs also positively regulate each other as seen for Cdx2 and Gata3 as well 
as Elf5, Eomes, and Tcfapc2c (Latos et al. 2015; Ralston et al. 2010). 
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1.2.3 Extra-embryonic Endoderm (XEN) cells  
Extra-embryonic endoderm (XEN) cells are derived from PrE of blastocyst-stage 
embryos and cultured in layer of MEF cells. These cells can contribute specifically to 
extra-embryonic endoderm layer when injected into blastocysts (Kunath et al., 2005). 
Very little is known about mechanism sustaining self-renewal of these cells. Recently, 
XEN cells have been established from ES cells by overexpressing Gata6 as well as by 
using retinoic acid and activin to convert ES cells to XEN-like cells (Niakan et al., 2013). 
As mentioned earlier, XEN cells also express Sox17, Gata4, and Sox7, which promote 
self-renewal of these cells. 
 
1.3 Transdifferentiation of ES cells to TS-like cells 
Early reprogramming methods such as somatic cell nuclear transfer (SCNT) and cell 
fusion demonstrated the flexibility of cellular identity. These experiments showed that it 
is possible to convert somatic cells back to an embryonic pluripotent state. This idea 
became the basis of the concept of lineage reprogramming, which is direct conversion of 
cells of one lineage to a different lineage (Graf and Enver, 2009). The feasibility of this 
was first demonstrated by a study showing that overexpression (OE) of single myogenic 
TF, MyoD, alone can covert fibroblasts into myoblasts (Davis et al., 1987). This led to 
variety of studies showing TF-mediated lineage reprogramming, including the conversion 
of monocytic precursors to erythroid-megakaryocytic cells using Gata1 and B cells to 
macrophages using C/EBPα or by ablation of Pax5 (Kulessa et al., 1995; Laiosa et al., 
2006; Nutt et al., 1999; Xie et al., 2004) and exocrine cells to islet β- cells using Pdx1, 
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Ngn3, and Mafa (Yechoor et al., 2009; Zhou et al., 2008). In recent years, pioneering 
studies have shown that somatic cells can be reprogrammed into induced pluripotent stem 
(iPS) cells through ectopic expression of four TFs: Oct4, Sox2, Klf4 and Myc (Takahashi 
and Yamanaka, 2006). Since then, several terminally differentiated cells such as 
cardiomyocytes, neuronal cells, hepatocytes and so on have been produced by 
reprogramming of other terminally differentiated cells, using combinations of various 
TFs (Heinrich et al., 2010; Huang et al., 2011, 2014; Ieda et al., 2010). Recently, various 
groups have also shown that ectopic expression of TFs, such as Tfap2c, Gata3, Eomes, 
Ets2 and Myc could generate induced TS-like (iTS) cells from MEFs (Benchetrit et al., 
2015; Kubaczka et al., 2015). These studies suggest that TFs can overcome lineage 
restrictions and facilitate lineage conversions. 
The transdifferentiation of ES cells to TS-like cells is an informative in vitro model to 
study mechanisms of the first cell fate decision and TE lineage development. The study 
of transdifferentiation has allowed us to understand what kind of factors affect the cell 
fate choice between two lineages that need to exist during the same developmental 
window. Studies have shown that controlled Oct4 repression, Cdx2 induction (Niwa et 
al., 2005), or forced activation of Ras/Erk signaling pathway in ES cells (Lu et al., 2008) 
lead to conversion of ES cells to TS-like cells and that ES cells deficient in DNA 
methylation can give rise to terminally differentiated trophoblast giant-like cells (Ng et 
al., 2008). In summary, transdifferentiation of ES cells to TS-like cells is an interesting 
tool that allows us to look at whether perturbation of one key factor is enough to induce 
TE lineage conversion programs in ES cells. Since human TS cells are not yet available, 
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it may be a valuable way to produce induced TS cells by transdifferentiation of human 
ES cells, which would be an excellent resource for cell therapy to treat pregnancy-related 
disorders. 
 
1.4 Role of Fosl1 in trophoblast lineage 
There are several TFs that regulate self-renewal and differentiation of TS cells, although 
their exact functions and molecular mechanisms were previously unknown. In particular, 
we decided to study Fosl1 (or Fra1). Fosl1 is a TF known to be upregulated in 
differentiated TS cells, but its detailed role in regulating differentiation has not been well 
characterized.  
 
1.4.1 PI3K/AKT signaling pathway  
The PI3K/AKT pathway is implicated in trophoblast cell development. Activation of 
PI3K upon trophoblast cell differentiation results in phosphorylation and activation of 
AKT. This signaling pathway in turn regulates the production of PRL family of genes, 
such as Prl3d1, Prl3b1, and Prl4a1 (Kamei et al., 2002). Fosl1 is one of the downstream 
mediators of PI3K/AKT pathway that controls the pro-invasive and pro-vascular 
remodeling phenotype of TS cells (Kent et al., 2011). Among the three isoforms of AKT 
(AKT1, AKT2, and AKT3), AKT1 is predominantly expressed in developing TGCs 
(Kamei et al., 2002; Yang et al., 2003). However, studies have suggested that each AKT 
isoform might play different roles in regulation of trophoblast cell phenotype as 
knockdown (KD) of individual AKT isoforms produce isoform-specific effects on the 
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genes related to invasion and vascular remodeling (Kent et al., 2011). Specifically, 
inhibition of PI3K/AKT results in the decrease in nuclear accumulation of Fosl1 while 
KD of Fosl1 leads to decreased expression of the genes associated with invasive-vascular 
remodeling and trophoblast invasion (Kent et al., 2011). However, what the precise 
mechanism behind Fosl1 regulation by PI3K/AKT pathway is unclear. In addition, 
PI3K/AKT pathway is implicated in placental disorders such as preeclampsia and 
intrauterine growth restriction (IUGR). Preeclampsia is characterized by poor trophoblast 
invasions leading to insufficient oxygen availability and fetal hypoxia (Goldman-Wohl 
and Yagel, 2002). IUGR is characterized by reduced fetal growth and some of the causes 
include inadequate placental development and trophoblast invasion (Scifres and Nelson, 
2009). In a preeclamptic placenta, the levels of AKT activity is increased due to 
upregulation of PI3K (Park et al., 2010), while in IUGR, expression of the AKT1 
pathway is downregulated (Yung et al., 2008). 
 
1.4.2 Fosl1  
Fosl1 is a component of activator-protein 1 complex (AP-1), consisting of Fos-Jun family 
dimerization, which is implicated in regulating cell proliferation and differentiation 
(Shaulian and Karin, 2002). The Fos family consists of c-Fos, FosB, Fosl1, and Fosl2, 
while the Jun family consists of c-Jun, Junb, and JunD. The AP-1 complex can consist 
either of Fos-Jun heterodimers or Jun-Jun homodimers (Eferl and Wagner, 2003). The 
composition of these dimers affects the activity of AP-1 and has been noted be cell type-
specific. In addition to differentiation of trophoblast cells, Fosl1 has also been implicated 
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in tumorigenesis, cancer progression, cell invasion (Verde et al., 2007), and bone 
development (Wagner, 2002). Additionally, Fosl1 null mice die due to placental defects 
at approximately E10.5 (Schreiber et al., 2000). However, the mechanism through which 
Fosl1 regulates its actions in trophoblast cells is not known. Therefore, Fosl1 is an 
excellent candidate to study the potential of a single TF to transdifferentiate ES cells to 
TS-like cells in order to gain insight into its mechanism.  
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Chapter 2: Materials and Methods 
 
2.1 Cell culture 
Mouse J1 ES cells were maintained in Dulbecco’s modified Eagle’s medium (DMEM, 
Gibco) supplemented with 18% fetal bovine serum (FBS), 50U/ml 
penicillin/streptomycin (Gibco), 2mM L-glutamine (Gibco), 100μM MEM nonessential 
amino acids (Gibco), nucleosides (Millipore), 100μM β-mercaptoethanol (Sigma) and 
1000U/ml recombinant leukemia inhibitory factor (LIF, Millipore). ES cells were 
cultured on 0.1% gelatin-coated plates. Mouse TS cells (a gift from Dr. Janet Rossant 
(University of Toronto) and Dr. Guang Hu (National Institutes of Health [NIH] / National 
Institutes of Environmental Health Sciences [NIEHS]) were maintained at a ratio of 3:7 
of TS medium to MEF-conditioned TS medium. The TS medium consisted of RPMI 
1640 (Gibco) supplemented with 20% FBS, 100μM β-mercaptoethanol, 2mM L-
glutamine, 1mM sodium pyruvate, 50U/mL penicillin, and 50mg/mL streptomycin. To 
acquire MEF-conditioned TS medium, mitomycin-treated MEF cells were cultured in TS 
medium for 3 days and the medium was collected every 3 days three times. The 3:7 ratio 
medium was supplemented with 25ng/mL Fgf4 and 1μg/mL heparin to maintain TS cells 
in self-renewing state and removed for differentiation of TS cells. HEK293T cells were 
maintained in DMEM supplemented with 10% FBS, 2mM L-glutamine, and 50U/mL 
penicillin/streptomycin. All cells were incubated in 37°C and 5% CO2. 
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2.2 Stable cell line generation 
Full length Fosl1 cDNA was cloned into pEF1a-FLBIO (FB) vector (Kim et al., 2009). 
The primer sequences used for cloning are listed in Table 1. Fosl1-containing vector (FB-
Fosl1) was introduced into BirA-expressing ES (BirA ES) cells by electroporation. These 
cells were allowed to grow under puromycin and geneticin selection for 9 days and 
colonies were picked and maintained under ES media conditions described above along 
with continuation of puromycin and geneticin selection. OE of Fosl1 was confirmed by 
RT-qPCR and Western blotting. Western blots were performed using anti-streptavidin-
HRP (1:2000, RPN1231V, GE Healthcare Life Sciences) and anti-Fosl1 (Fra-1 (N-17)) 
antibody (1:500, sc-183, Santa Cruz). 
 
2.3 Western blotting 
For whole cell lysate preparation, cells were washed with PBS, and lysed in 2X Laemelli 
sample buffer (Bio-rad). The cells lysates were boiled at 100°C for 15 min and 
centrifuged prior to loading. Proteins were separated on 4-20% gradient acrylamide gels 
(Bio-rad) and transferred onto PDVF membrane using Trans-Blot® Turbo™ Transfer 
Starter System (Bio-rad). After protein transfer, membranes were blocked with 5% BSA 
(Sigma) in TBST (20mM Tris-HCl, pH 7.6, 13 mM NaCl, and 0.1% Tween-20) for 1 
hour and incubated with primary antibody at 4°C overnight. The membranes were then 
washed with TBST and incubated with secondary antibody for 1 hour at room 
temperature. The proteins were detected using ECL reagents (GE Healthcare Amersham 
ECL prime) with Bio-rad Molecular Imager® ChemiDoc™ XRS+ system. The 
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antibodies used are anti-Fra-1 (N-17) (1:500, sc-183, Santa Cruz) and anti-β-actin 
(1:20000, ab20272, Abcam). 
 
2.4 Alkaline Phosphatase (AP) staining 
Alkaline Phosphatase (AP) staining was performed according to manufacturer’s protocol 
using Alkaline Phosphatase Detection Kit (Millipore). Cells were imaged using an 
inverted microscope. 
 
2.5 Real time-quantitative PCR (RT-qPCR) 
Total RNA was isolated using RNeasy plus Mini Kit (Qiagen). 500ng of total RNA was 
used for cDNA synthesis with ReadyScript® cDNA Synthesis Mix (Sigma). The cDNA 
generated was diluted 20X and RT-qPCRs were performed using 2μl of diluted cDNA 
with PerfeCTa SYBR® Green FastMix, Low ROX™ (Quanta). RT-qPCR primers were 
designed to amplify exon junctions and their sequences are listed in Table 1. Gapdh was 
used as an internal control to normalize variability in expression levels.  
 
2.6 Bio-ChIP-sequencing (Bio-ChIP-seq) 
Bio-ChIP assays were performed using BirA ES cell lines- expressing BirA only 
(control) or BirA and biotin-tagged proteins (sample) as previously described (Kim et al., 
2009) using streptavidin magnetic particles. Briefly, cells were cross-linked in 1% 
formaldehyde for 7 min at room temperature and the reaction was quenched for 5 minutes 
by adding glycine to final concentration of 125mM. Fixed cells were rinsed with PBS 
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twice and centrifuged. The fixed cell pellets were used immediately for experiments or 
stored at -80°C. 
Cells were re-suspended in ChIP buffer (1% TritonX-100, 2mM EDTA, 20mM TrisCl, 
pH 8.1, 150mM NaCl, 0.1% SDS, and protease inhibitor), and then sonicated for 30 min 
(30 sec on / 1 min off) and centrifuged at maximum speed for 10 min. The supernatant 
was transferred to new tubes and pre-cleared with Protein A beads for 4 hours, rotating in 
4°C. The samples were then centrifuged and the supernatant was incubated in 10μg 
streptavidin beads overnight (Roche). The beads were washed for 8 minutes, twice with 
2% SDS, once with high salt buffer (0.1% Deoxycholate, 1% Triton X-100, 1mM EDTA, 
50mM HEPES (pH 7.5), and 500mM NaCl), once with LiCl wash buffer (250mM LiCl, 
0.5% NP40, 0.5% Deoxycholate, 1mM EDTA, and10mM TrisCl pH 8.1) and twice with 
TE buffer. Samples were eluted by incubating the beads in 150μl of SDS Elution buffer 
(1% SDS, 10mM EDTA, and 50mM TrisCl pH 8.1) overnight in 65°C water bath, then 
for 30 min in 65°C water bath with 50ul of SDS Elution buffer. 200μl of TE buffer was 
added to the eluted samples and were treated with 1μg RNase A for 30 minutes in 37°C 
and 1μg Protease K for at least 2 hours in 37°C.  
ChIP-seq library prep kits (New England BioLabs) were used to generate ChIP-seq 
libraries and samples were sequenced using Illumina HiSeq 2500 sequencer at the 
Genomic Sequencing and Analysis Facility (GSAF) of The University of Texas at 
Austin. 
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2.7 RNA-sequencing (RNA-seq) 
Total RNA was extracted using RNeasy® Plus Mini Kit (Qiagen). 1μg of RNA was used 
to prepare libraries for RNA-seq using NEBNext® Poly(A) mRNA Magnetic Isolation 
Module (New England BioLabs). RNA-seq libraries were sequenced using Illumina 
HiSeq 2500 sequencer at the Genomic Sequencing and Analysis Facility (GSAF) of The 
University of Texas at Austin. 
 
2.8 shRNA-mediated knockdown (KD) 
HEK293T cells were plated in 6-well plate and incubated overnight. Cells were 
transfected with 1200ng of pLKO-neo empty or pLKO-neo Fosl1 shRNA with 800ng of 
Δ8.9 and 400ng of VSVG helper plasmids using Fugene (Promega), according to 
manufacturer’s instruction. After 24 hours, HEK293T medium was replaced with TS 
media (without Fgf4 and heparin). 48 hours after transfection, supernatants containing 
viral particles were collected and filtered through 0.45μm pore size filters. For infection, 
1.5 X 10^5 TS cells were plated in 24-well plate with virus-containing supernatant 
supplemented with polybrene (Millipore). To observe the effect of Fosl1 KD during 
differentiation, TS cells were expanded to 6-well plates under differentiation condition 
(media without Fgf4 and heparin). 
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Chapter 3: Results 
3.1 Overexpression (OE) of Fosl1 in ES cells leads to differentiation of ES cells to 
TS-like cells 
In order to investigate the functions of Fosl1, we monitored the mRNA expression levels 
of Fosl1 in TS cells and differentiating TS cells. We found that the level of Fosl1is higher 
in differentiating TS cells (Figure 1A), indicating that Fosl1 expression increases over 
the course of differentiation of TS cells. To examine whether Fosl1 can promote 
transdifferentiation of ES cells to TS-like cells, we generated stable cell line of Fosl1 
overexpressing BirA ES cells. BirA ES cells serve as a control. Using RT-qPCR and 
Western blot, we validated ectopic expression of Fosl1 (Figure 1B). Compared to the 
typical round-shaped colony morphology of control ES cells, Fosl1 OE cells displayed 
differentiated (flattened) morphology along with weak AP activity, indicative of the exit 
of ES cell pluripotency (Figure 1B). We also investigated how OE of Fosl1 affects the 
expression of various lineage markers using RT-qPCR. We found that the expression 
levels of ES pluripotency-associated genes, such as Oct4, Nanog and Sox2, remained 
similar to that of control ES cells while the expression levels of marker genes 
representing mesoendoderm, ectoderm, and mesoderm lineages were either similar to or 
lower than the control ES cells (Figure 1C). However, RT-qPCR revealed that markers 
associated with differentiated TS cells such as Gata3, Hand1, Krt8, Plf and Tead3 were 
significantly upregulated (Figure 1C). This suggests that Fosl1 activates genes associated 
with differentiated TE lineage. Even though some TS self-renewal markers such as 
Tead4, Id2 and Arid3a showed slight upregulation, levels of other TS self-renewal 
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marker such as Cdx2, Eomes, Elf5 and Esrrb did not show significant change compared 
to control (Figure 1C), which further suggest that Fosl1’s role in TS cells is related to 
differentiation rather than self-renewal. These results prompted us to look at the 
expression level of Fosl1 is in Fosl1 OE cells, compared to TS cells and differentiating 
TS cells. We found that the expression of Fosl1 was almost 40 fold higher in Fosl1 OE 
cells compared to TS cells, confirming that OE was successful. In contrast, Fosl1 levels 
in Fosl1 OE cells were comparable to that of differentiated (Day 3) TS cells (Figure 2). 
This suggested that Fosl1 OE cells are physiologically similar to differentiated TS cells, 
with regards to Fosl1 expression level. Collectively, these results indicated that Fosl1 
might possess potential to direct ES cells to differentiated TS-like cells. 
 
3.2 Fosl1 OE leads to global induction of TS differentiation markers as well as 
Prolactin (Prl) family genes 
To get a more comprehensive idea of how Fosl1 OE impacts the global transcriptional 
program, we performed RNA-seq. The expression analysis confirmed that the levels of 
Oct4, Sox2 and Nanog (ES pluripotency factors) as well as markers of various lineages, 
such as Gsc, Cxcr4 (mesoendoderm), Fgf5, Otx2, Nes, Hoxb1 (ectoderm), Gata4, Gata6, 
Sox17, Isl1 (endoderm) and Bmp2 (mesoderm) were similar between Fosl1 OE cells and 
control ES cells (Figure 3A, 3B). Consistent with our RT-qPCR data, we were also able 
to confirm that the levels of TS self-renewal markers such as Cdx2, Elf5, Esrrb, and 
Tcfap2c have not changed significantly in Fosl1 OE cells compared to control ES cells 
(Figure 3C). On the other hand, TS differentiation markers, such as Hand1, Krt8, and 
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H19 were upregulated upon OE of Fosl1 in ES cells (Figure 3D). It is possible that we 
did not observe decrease in the expression of TS self-renewal markers since it has been 
noted that TS cells derived from Cdx2-/-, Eomes-/-, and Tead4-/- embryos fail to 
differentiate or form TGCs, when cultured in vitro (Strumpf et al. 2005; Nishioka et al. 
2008). Among the genes that were induced upon Fosl1 OE, we found that H19 was one 
of the very highly upregulated genes (Figure 3D). It has been shown that induction of 
H19, a noncoding RNA, leads to commitment of mouse ES cells to trophoblast lineages 
(Fujimori et al. 2013). We also found that expression of members of Prolactin (Prl) 
family, such as Prl2c2, Prl2c5, Prl2a1, and Prl3d1 is also elevated (Figure 3E). Given 
that TGCs have been characterized by expression of the Prl gene family (Hamlin et al., 
1994; Sahgal et al., 2005), increased level of such genes suggests that Fosl1 OE cells 
have similar transcriptional landscape to differentiated TS cells, and perhaps have been 
converted into trophoblast giant-like cells.  
 
3.3 GSEA analysis reveals that Fosl1 OE cells possess characteristics of 
differentiated TS cells 
We further performed Gene Set enrichment analysis (GSEA) to compare the gene 
expression profile of Fosl1 OE cells to those of ES cells (GSE3766, Ralston et al. 2010) 
and TS cells (GSE12985, Ralston et al. 2010). As seen in Figure 4A, genes enriched 
upon Fosl1 OE were found to have negative correlation with ES cell-specific gene set, 
while the analysis revealed that there was no significant correlation with TS cell-specific 
gene set. Since upregulation of differentiated TS cell markers was observed in Figure 
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1C, we wanted to investigate which stage of differentiating TS cells are similar to Fosl1 
OE cells. To do this, we used a published dataset obtained from time-course 
differentiation of TS cells for 6 days (GSE12985, Ralston et al. 2010) (Figure 4B). 
Remarkably, we found that correlation between genes upregulated upon Fosl1 OE 
increased as the differentiation of TS cells progressed, with the highest correlation seen at 
differentiation day 6. This implied that genes that are upregulated upon differentiation of 
TS cells are also upregulated upon Fosl1 OE in ES cells and thus, transdifferentiate ES 
cells to differentiated TS-like cells.  
Since it has been noted that TS cells undergo epithelial-mesenchymal transition (EMT) as 
they differentiate (Sutherland, 2003), we examined the correlation between EMT gene set 
and gene expression pattern obtained from Fosl1 OE in ES cells and found that there was 
a high correlation with genes enriched upon Fosl1 OE (Figure 4C). Significant 
enrichment was observed for genes, such as Serpine2, Col4a1, Col4a2, Col5a1, Col7a1, 
Itga5, Itgb5, Ecm1, and Mmp14 upon Fosl1 OE.  
There was also a noticeable negative correlation with genes specific for G2 to M 
checkpoint of cell cycle (Figure 4C). We found that levels of genes, such as AurkA, 
Chek1, Cdkn1b, Cdc6, and Hus1 are lower in Fosl1 OE cells. These data support our 
observations in Figure 1B, in which Fosl1 OE cells are larger in size and show prominent 
nuclei, suggesting that Fosl1 OE cells might undergo endoreplication, which is a 
hallmark of non-proliferating TGCs (DePamphilis et al., 2012). These results suggest that 
Fosl1 OE cells are indeed biased towards differentiated TE lineage, particularly the TGC 
subtype. 
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3.4 Chromosomal targets of Fosl1 reflects its function in ES cells to TS-like cells 
transdifferentiation 
In order to map the global target loci of Fosl1, we used in vivo biotinylation-mediated 
ChIP followed by massive parallel sequencing (Bio-ChIP-seq) We found that Fosl1 
occupies primarily intergenic (~50%) and intron (~41%) regions of the genome (Figure 
5A). Genomic Regions Enrichment of Annotations Tool (GREAT) analysis revealed that 
Fosl1 binding occurs mostly within 50 to 500 kb from the transcription start sites (TSS) 
of well annotated genes (Figure 5A). Interestingly, we found that Fosl1 binds to its own 
promoter and distal enhancer regions (Figure 5B), indicating that Fosl1 may form an 
auto-regulatory loop and activate its own transcription. Examples of such loop have been 
known for master regulators of ES cells, such as Oct4, Sox2 and Nanog, which form 
“interconnected auto-regulatory loops” (Boyer et al., 2005). This suggests that Fosl1 
might also possess properties of a key regulator for TS cell differentiation. We also found 
that Fosl1 occupies a larger region of Junb gene (one of the components of AP-1 dimer 
complex) (Figure 5B), which suggests that Fosl1 predominantly works with Junb as part 
of its action mechanism. 
In addition, Fosl1 also occupied large set of genes upregulated upon differentiation of TS 
cells, including Krt8, Bhlhe40, Gata2, and Ovol2 (Figure 5C). This shows that Fosl1 
might bind to and regulate these genes for transition of ES cells to differentiated TS-like 
cells. When we tested Fosl1 occupancy for the genes associated with self-renewal of TS 
cells, we found that it occupies regions of genes such as Esrrb, Eomes, Tead4, and Elf5 
(Figure 5D). This is unexpected since we did not see dramatic changes in expression 
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levels of these genes upon OE of Fosl1 in ES cells by RT-qPCR (Figure 1C) and RNA-
seq (Figure 3C). What this suggests is that Fosl1 not only orchestrates the differentiation 
of TS cells, but also sustains the TS-specific gene expression. 
Furthermore, we also found Fosl1 occupancy for Oct4 but not Nanog or Sox2 (Figure 
5E), which is also surprising since we do not see significant downregulation of Oct4 
upon Fosl1 OE. This could suggest that Fosl1 is the downstream executor of Oct4-
depletion mediated TE differentiation or that Fosl1 acts through a pathway independent 
of Oct4-depletion mediated TE differentiation. 
We also found that Fosl1 also occupies regulatory regions of EMT-associated genes such 
as Epcam, Vim, and various matrix metalloproteinase including Mmp9, Mmp14, and 
Mmp28 (Figure 5F). This implies that Fosl1 directly regulates these genes and 
modulates differentiation of TS cells by activating EMT. 
 
3.5 Gene Ontology (GO) analysis reveals role of Fosl1 related to placental 
development 
Gene ontology (GO) analysis of Fosl1 targets showed significant enrichment in processes 
associated with placental development, trophectodermal cell differentiation, cell junction 
organization/assembly, and adherens junction organization (Figure 6A). GREAT 
analysis also revealed that dysregulation of Fosl1 targets leads to mouse phenotype 
associated with abnormal trophoblast layer morphology, abnormal TGCs, and abnormal 
cell adhesion, implicating the roles of Fosl1 in these processes in vivo (Figure 6B). In 
addition, GO molecular processes showed that targets of Fosl1 are enriched in the 
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processes of phosphatidylinositol 3-kinase (PI3K) binding (Figure 6C). This confirms 
the results of previous studies showing that Fosl1 is a downstream effector of PI3K-AKT 
pathway (Kent et al., 2011). This further emphasizes the important role of Fosl1 in 
transdifferentiation of ES cells to giant-like cells as an active PI3K pathway favors TGCs 
and survival of TGCs are influenced by PI3K signaling (Kent et al., 2010). Mouse 
Genome Informatics (MGI) expression patterns of Fosl1 targets also show that normal 
trophectoderm development is affected at an early time point upon dysregulation of Fosl1 
targets (Figure 6D). Therefore, these results reinforce our hypothesis that Fosl1 is crucial 
for TE development and that Fosl1 OE can initiate TE differentiation program in ES 
cells. 
 
3.6 ChIP-seq data reveals that Fosl1 acts as an activator of genes associated with TE 
lineage 
In order to understand how Fosl1 regulates transdifferentiation of ES cells to TS-like 
cells, we compared the gene expression profile of Fosl1 OE cells with target occupancy 
of Fosl1, using moving window average (Figure 7A). We found that most of the genes 
that were upregulated upon Fosl1 OE were direct targets of Fosl1. However, genes 
downregulated upon OE of Fosl1 were not the direct targets of Fosl1. This demonstrates 
that Fosl1 acts an activator and not a repressor of target gene transcription. This is similar 
to Cdx2, one of the key regulators of TE lineage, for which upregulation of its target 
genes upon OE in ES cells is accomplished by direct binding, but not for downregulated 
genes (Nishiyama et al., 2009). 
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 In addition, motif analysis of Fosl1 targets identified the known Fosl1 binding motif 
(TGAGTCA) as well as Junb binding motif (predicted by GREAT) (Figure 7B). This 
result implies that Fosl1 may regulate its targets with Junb which supports previous 
studies suggesting that Fosl1 and Junb interaction might be the critical determinant of 
regulation of the target genes by Fosl1 (Seldeen et al., 2009).  
 
3.7 Fosl1 knockdown (KD) impedes differentiation of mouse TS cells to TGCs 
In order to validate the role of Fosl1 in differentiation of TS cells, we used shRNA-
mediated KD to downregulate the levels of Fosl1 in mouse TS cells. We cultured control 
TS cells (pLKO-neo empty) and Fosl1 KD cells in differentiation condition (without Fgf4 
and heparin) and collected samples at Day 3 and Day 7 of differentiation. We observed 
that at Day 3, while control TS cells started to acquire differentiation morphology, Fosl1 
KD cells maintained undifferentiated morphology (Figure 8A). By Day 7, control TS 
cells had differentiated into giant cells and formed clumps (signs of TS cell 
differentiation), Fosl1 KD cells showed a smaller number of giant cells and majority of 
undifferentiated morphology was still prevalent. Fosl1 KD was verified using RT-qPCR 
(Figure 8B). Upon differentiation, TS self-renewal marker, Esrrb was highly maintained 
in Fosl1 KD cells, compared to control TS cells (Figure 8C). RT-qPCR also showed that 
genes upregulated upon differentiation of TS cells, such as Hand1, Prl3da, and Prl15a, 
were not activated in Fosl1 KD cells upon differentiation, compared to control TS cells 
(Figure 8D). These data show that Fosl1 is necessary for proper and timely upregulation 
of TS cell differentiation markers. Interestingly, marker of spongiotrophoblast, (a subtype 
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of differentiated TS cells), Flt1, had begun to increase by Day 7 of differentiation, 
specifically Flt1 (Figure 8E). This suggests that Fosl1 is critical for TS cell 
differentiation to TGCs, and that in its absence, TS cells may differentiate into other 
subtype of TS cells, specifically spongiotrophoblast. This highlights the importance of 
studying the roles of TS cell-specific TFs in placental development, as improper 
differentiation can lead to serious health risks during pregnancy, including preeclampsia.  
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Chapter 4: Discussion 
In this study, we have established that the ectopic expression of Fosl1 is sufficient to 
transdifferentiate ES cells to differentiated TS-like cells. Our results reveal that Fosl1 acts 
as a transcriptional activator of its target genes, and most of the genes that are 
upregulated upon Fosl1 OE are involved in biological processes involved in placental 
development, trophectodermal cell differentiation, adherens junction organization and 
other TE-related processes. Surprisingly, we did not observe drastic downregulation of 
ES cell core factors such as Oct4, Sox2, and Nanog upon Fosl1 OE in ES cells. It is 
possible that Fosl1 acts independently of Oct4 depletion-mediated differentiation or that 
Fosl1 is a downstream executor of Oct4 depletion-mediated differentiation. Since Junb is 
known to act as a negative regulator of cell proliferation in fibroblasts, it is possible that 
Junb, which dimerizes with Fosl1, acts as a repressor during transdifferentiation of ES 
cells to TS-like cells (Shaulian and Karin, 2002). In addition, we also did not see 
downregulation of TS self-renewal markers such as Cdx2, Eomes, and Tead4 upon OE of 
Fosl1 in ES cells. Studies have shown that when cultured in vitro, Cdx2-/-, Eomes-/-, and 
Tead4-/- embryos fail to differentiate or form TGCs (Nishioka et al., 2008; Strumpf et al., 
2005). Therefore, it is plausible that sustained expression of these markers is important 
for Fosl1-mediated ES cells to TS-like cells transdifferentiation, which leads to cells with 
properties of differentiated TS cells.  
We also observed a strong positive correlation of genes upregulated upon Fosl1 OE and 
genes upregulated upon TS cell differentiation. In addition, we found upregulation of Prl 
family genes, which are associated with TS cell differentiation, upon Fosl1 OE. 
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Crucially, we observed that KD of Fosl1 in TS cells led to delay in differentiation of TS 
cells compared to control cells. Additionally, gene involved in differentiation of 
spongiotrophoblast subtype was upregulated by Day 7 in Fosl1 KD TS cells, while genes 
involved in differentiation towards TGCs were not, indicating that Fosl1 is required for 
differentiation of TS cells to TGCs. GREAT analysis revealed that dysregulation of Fosl1 
leads to mouse phenotype associated with abnormal trophoblast layer morphology and 
abnormal TGCs. All these indicate that Fosl1 is an important regulator of TGC 
development.  
We also found that Fosl1 binds to its own regulatory elements, in addition to TE-specific 
gene. Such autoregulatory loops are properties of master regulators as shown in ES cells 
(Boyer et al., 2005). This indicates that Fosl1 might be a key regulator of differentiation 
of TS cells. In lieu of these findings, it is important to test closely the role of Fosl1 in 
placental development. Differentiated cell types in TE lineages have numerous functions, 
including invasion into maternal uterine vasculature (Adamson et al., 2002; Hemberger et 
al., 2003), endocrine functions, regulation of maternal-fetal nutrient/gas exchange, and 
excretion of fetal waste (Rossant and Cross, 2001; Soares et al., 1996). Therefore, it is 
essential to gain better understanding of TE lineage differentiation in order to understand 
diseases associated with dysregulation of such cell types. As a key downstream mediator 
of PI3K/AKT pathway, which is involved in preeclampsia and IUGR, Fosl1 can give us 
insight into these diseases, and may be even used as a therapeutic target in the future. 
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Figure 1, continued on next page 
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Figure 1: Expression levels of various lineage markers in Fosl1 OE cells l. (A) 
Expression analysis of Fosl1 in TS cells, and D3, D4 differentiating TS cells. (B) ES cells 
morphology upon overexpression of Fosl1. Fosl1 OE cells were cultured for 3 days and 
stained for Alkaline Phosphatase (AP). Protein and mRNA levels of Fosl1 following 
Fosl1 OE as measured by Western Blot and RT-qPCR. B-actin was used as loading 
control. (C) Expression analysis of ES pluripotency-associated genes, lineage markers 
(mesoendoderm (orange); ectoderm (green); mesoderm (blue)) and TS self-renewal and 
differentiation markers by RT-qPCR, compared to control.  
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Figure 2: Fosl1 levels in Fosl1 OE, TS, and differentiating TS cells. Expression analysis 
of Fosl1 in Fosl1 OE cells, compared to TS cells and D3 differentiating TS cells. 
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Figure 3: Fosl1 OE leads to global induction of TS differentiation markers. (A, B, C, D, 
E) RNA-seq analysis confirming expression of (A) ES pluripotency-associated genes in 
Fosl1 OE cells, (B) Lineage-associated genes (mesoendoderm (orange); ectoderm 
(green); endoderm (pink), mesoderm (blue)) in Fosl1 OE cells. (C) TS self-renewal 
markers, (D) TS differentiation markers (E) Prolactin (Prl) family markers. RNA-seq data 
with RPKM values is available in supplementary material. 
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Figure 4: Fosl1 OE cells possess properties of differentiated TS cells. (A, B, C) GSEA 
analysis using ordered gene expression levels from Fosl1 overexpressing cells and 
control ES cells. Normalized enrichment score (ES) and false discovery rate (FDR) are 
shown. (A) GSEA using top 500 highly expressed in genes in ES cells (GSE3766), and 
TS cells (GSE12985). (B) GSEA using top 500 genes upregulated at different time points 
of TS cells differentiation (GSE12985). (C) GSEA analysis using GSEA dataset using 
genes correlated upon epithelial-mesenchymal transition (EMT) and G2 to M checkpoint 
of cell cycle. The gene sets used for GSEA analysis is available in supplementary 
material.  
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Figure 5, continued on next page 
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Figure 5, continued on next page 
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Figure 5: Chromosomal targets of Fosl1 reveals its function in ES cells to TS-like cells 
transdifferentiation. (A) Pie chart representing distribution of Fosl1 peaks. Bar graph 
showing pattern of Fosl1 binding at various regions with respect to distance to TSS. (B, 
C, D, E, F) Snapshots of ChIP-seq signal tracks of Fosl1 and Oct4 at regulatory regions 
of (B) Fosl1 and Junb (C) TS differentiation markers (D) TS self-renewal markers (E) 
Oct4 and (F) EMT-associated genes.  
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Figure 6, continued on next page 
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Figure 6: Gene Ontology analysis reveals Fosl1’s role in placental development. (A) 
Significantly enriched terms related to biological processes upon upregulated genes upon 
Fosl1 OE by Gene ontology (GO). (B) Mouse phenotype affected upon dysregulation of 
genes regulated by Fosl1. (C) Significantly enriched terms related to molecular processes 
upon upregulated genes upon Fosl1 OE by Gene ontology (GO). (D) Endogenous gene 
expression of genes affected by Fosl1 OE during mouse development by Mouse Genome 
Informatics (MGI). 
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Figure 7: Fosl1 acts as an activator of genes associated with TE lineage. (A) A heat map 
representation of expression profile of Fosl1 overexpressing cells denoting TE-specific 
genes and pluripotency-associated genes. Genes were ordered according to gene 
expression levels in Fosl1 overexpressing cells relative to control ES cells. Moving 
average with window size of 250 was plotted to corresponding Fosl1 occupancy signals. 
(B) Motif analysis of Fosl1 target loci indicates high overlap with target motif of Junb. 
ChIP-seq occupancy scores are available in supplementary material. 
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Figure 8, continued on next page 
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      Figure 8, continued on next page 
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Figure 8: Fosl1 KD in TS cells hinders formation of TGCs. (A) Morphology of control 
TS cells and TSC with Fosl1 knockdown (KD) at various time points (D3 and D7) of 
differentiation. (B) mRNA level of Fosl1 in Fosl1 KD TS cells compared to control TS 
cells. Expression analysis of various (C) TS cell self-renewal markers (D, E) TS cell 
differentiation markers, by RT-qPCR. 
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Table 1: Primers and shRNA sequences 
 
RT-qPCR primers 
  Forward  Reverse 
Arid3a AGGTTATCAACAAGAAACTGTGGAG TACTTCATGTACTGTGTCCGAAGTG 
Bmp4 GAGTTTCCATCACGAAGAACATCT AGGAGATCACCTCATTCTCTGG 
Cdx2 GCGAAACCTGTGCGAGTGGATG CGGTATTTGTCTTTTGTCCTGGTTTTCA 
Elf5 CAAGGTTACTCCTTTTTCAATGATG GCTGTGACAGTCTTGACTCTTGAT 
Eomes ATAAGATGTACGTTCACCCAGAATC GCACCTTTGTTATTGGTGAGTTTTA 
Esrrb TAAAAAGCCATTGACTAAGATCGTC CAATTCACAGAGAGTGGTCAGG 
Fgf5 GGATTGTAGGAATACGAGGAGTTTT AACTTACAGTCATCCGTAAATTTGG 
Flt1 TCTACCAAATCATGTTGGATTGCTG ATGTAATCTTTCCCATCCTGTTGGA 
Fosl1 CTAAGTGCAGAAACCGAAGAAAG CTTCTGCAGCTCTTCAATCTCTC 
Gapdh AAATTCAACGGCACAGTCAAG CACCCCATTTGATGTTAGTGG 
Gata3 TGGGCTGTACTACAAGCTTCATAA CTTTTTCGATTTGCTAGACATCTTC 
Gsc AGAAGGTGGAGGTCTGGTTTAAG GAGGACGTCTTGTTCCACTTCT 
Hand1 CCTTCAAGGCTGAACTCAAAAA GCGCCCTTTAATCCTCTTCT 
Id2 ATCACCAGAGACCTGGACAGAAC GCTATCATTCGACATAAGCTCAGA 
Krt8 AGAATGAATTTGTCCTCATCAAGAA GAAGTTGATCTCGTCGGTCAGTC 
Nanog AGGGTCTGCTACTGAGATGCTCTG CAACCACTGGTTTTTCTGCCACCG 
Oct4 TCTGGAGACCATGTTTCTGAAGT TACAGAACCATACTCGAACCACAT 
Otx2 AAGTGAGTTCAGAGAGTGGAACAAG CTCCAGATAGACACTGGAGCACT 
Prl3d1 ACTGAAGACCTGTATACTCGTTTGG GGAAGTGTTCTGTCTGTTATCCAAG 
Prl5a1 GATCTCGATGGAACTCCTTATGTTA TCAGGATTAACCTGGCTGAGTATAG 
Sox2 GCGGAGTGGAAACTTTTGTC TATTTATAATCCGGGTGCTCCT 
T CTTCAAGGAGCTAACTAACGAGATG GTCCAGCAAGAAAGAGTACATGG 
Tcfap2c CCTAGTAAAGCGGTGGCTGA GAACTCCTTGCACACCTGCT 
Tead3 AAAACCAGGACAAGAAAACAGGT GAGAGCTTTGTCCTTGGAGACTT 
Tead4 ATGACAAGTTCCCAGAGAAGAAG GTCATCGATGTTGGTATTGAGGT 
 
Cloning  primers 
 
Forward Reverse 
FB-Fosl1 
CCGAGCTCGAGGATCCTCAT 
GTACCGAGACTACGGGGA 
TAGAACTAGTGGATCCTCACA 
AAGCCAGGAGTGTAG 
 
Table 1, continued on next page 
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  Forward  Reverse 
shFosl1-
1 
CCGGCGACAAATTGGAGGATGA 
GAACTCGAGTTCTCATCCTCCAA 
TTTGTCGTTTTTG 
AATTCAAAAACGACAAATTGGAG 
GATGAGAACTCGAGTTCTCATCCT 
CCAATTTGTCG 
shFosl1-
2 
CCGGCCAGTGCCTTGCATCTCC 
CTTCTCGAGAAGGGAGATGCAA 
GGCACTGGTTTTTG 
AATTCAAAAACCAGTGCCTTGCAT 
CTCCCTTCTCGAGAAGGGAGATGC 
AAGGCACTGG 
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